← SynDRA
TALMAPIMOD
SynDRA canonical compound SYN0016522 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | MAPK14 |
| Mechanism of action | P38 MAPK inhibitor |
All known targets
- MAPK14
- IL1B
- MAPK11
- MT-CO2
- TNF
Mechanisms of action (all sources)
- MAPK14 INHIBITOR
- MAP kinase p38 alpha inhibitor
- MAPK14 MODULATOR
Cross-references
Synonyms
- SCIO-469
- SCIO 469
- Scios 469
- UNII-B1E00KQ6NT
- B1E00KQ6NT
- CHEMBL514201
- SCIO 469 hydrochloride
- CHEBI:90683
- Talmapimod hydrochloride
- 2-(6-Chloro-5-{[(2r,5s)-4-(4-Fluorobenzyl)-2,5-Dimethylpiperazin-1-Yl]carbonyl}-1-Methyl-1h-Indol-3-Yl)-N,N-Dimethyl-2-Oxoacetamide
- 2-[6-chloro-5-[(2R,5S)-4-[(4-fluorophenyl)methyl]-2,5-dimethylpiperazine-1-carbonyl]-1-methylindol-3-yl]-N,N-dimethyl-2-oxoacetamide
- Talmapimod [USAN]
- Talmapimod [USAN:INN]
- 309913-83-5 (free base)
- 2-(6-chloro-5-((2R,5S)-4-(4-fluorobenzyl)-2,5-dimethylpiperazine-1-carbonyl)-1-methyl-1H-indol-3-yl)-N,N-dimethyl-2-oxoacetamide
- 1H-Indole-3-acetamide, 6-chloro-5-[[(2R,5S)-4-[(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]carbonyl]-N,N,1-trimethyl-alpha-oxo-
- 1H-Indole-3-acetamide, 6-chloro-5-(((2R,5S)-4-((4-fluorophenyl)methyl)-2,5-dimethyl-1-piperazinyl)carbonyl)-N,N,1-trimethyl-alpha-oxo-
- 2-(6-chloro-5-(((2R,5S)-4-(4-fluorobenzyl)-2,5-dimethylpiperazin-1-yl)carbonyl)-1-methyl-1H-indol-3-yl)-N,N-dimethyl-2-oxoacetamide
- 2-[6-Chloro-5-[[(2R,5S)-4-(4-fluorobenzyl)-2,5-dimethylpiperazin-1-yl]carbonyl]-1-methyl-1H-indol-3-yl]-N,N-dimethyl-2-oxoacetamide
- TALMAPIMOD [INN]
- Talmapimod (USAN/INN)
- TALMAPIMOD [WHO-DD]
- SCIO469
- MLS006010308
- GTPL7817
- SCHEMBL4779242
- DTXSID10953119
- BDBM50266947
- NSC777446
- NSC800941
- ZINC34001955
- CS-5645
- DB05412
- NSC-777446
- NSC-800941
- NCGC00263140-01
- NCGC00263140-03
- HY-10406
Look up TALMAPIMOD in the interactive SynDRA portal →